AJP - Heart and Circulatory Physiology, Vol 270, Issue 5 1634-H1639, Copyright © 1996 by American Physiological Society

ARTICLES

PKC inhibitors prevent endothelial dysfunction after myocardial ischemia-reperfusion in rats

K. Numaguchi, H. Shimokawa, R. Nakaike, K. Egashira and A. Takeshita
Research Institute of Angiocardiology, Kyushu University School of Medicine, Fukuoka Japan.

The intracellular mechanism for endothelial dysfunction after myocardial ischemia-reperfusion remains to be elucidated. It has been reported that activation of protein kinase C (PKC) occurs after myocardial ischemia-reperfusion and that the activation impairs endothelium-dependent relaxation. Thus we examined the role of PKC activation in the ischemia-reperfusion-induced endothelial dysfunction. Isolated rat hearts perfused with a constant flow were subjected to global ischemia for 15 min followed by reperfusion for 20 min. Coronary vascular responses to the endothelium-dependent vasodilators acetylcholine (ACh) and bradykinin (BK) and the endothelium-independent vasodilator sodium nitroprusside (SNP) were examined before and after the ischemia-reperfusion. Endothelium-dependent relaxations to ACh and BK were impaired after the ischemia-reperfusion, whereas endothelium-independent relaxations to SNP were unaffected. Pretreatment with a PKC inhibitor, staurosporine, H7, or calphostin C, prevented the impairments. Phorbol 12-myristate 13-acetate, a PKC-activating phorbol ester, attenuated the relaxations to ACh and BK but not those to SNP. These results suggest that PKC activation may be involved in part in the ischemia-reperfusion-induced endothelial dysfunction.

This article has been cited by other articles:

				J. P. Headrick, B. Hack, and K. J. Ashton Acute adenosinergic cardioprotection in ischemic-reperfused hearts Am J Physiol Heart Circ Physiol, November 1, 2003; 285(5): H1797 - H1818. [Abstract] [Full Text] [PDF]

				N. Kanno, G. LeSage, S. Glaser, and G. Alpini Regulation of cholangiocyte bicarbonate secretion Am J Physiol Gastrointest Liver Physiol, September 1, 2001; 281(3): G612 - G625. [Abstract] [Full Text] [PDF]

				S.-F. Yan, J. Lu, Y. S. Zou, W. Kisiel, N. Mackman, M. Leitges, S. Steinberg, D. Pinsky, and D. Stern Protein Kinase C-beta and Oxygen Deprivation. A NOVEL Egr-1-DEPENDENT PATHWAY FOR FIBRIN DEPOSITION IN HYPOXEMIC VASCULATURE J. Biol. Chem., April 14, 2000; 275(16): 11921 - 11928. [Abstract] [Full Text] [PDF]

				C. D. Collard, A. Agah, W. Reenstra, J. Buras, and G. L. Stahl Endothelial Nuclear Factor-{kappa}B Translocation and Vascular Cell Adhesion Molecule-1 Induction by Complement : Inhibition With Anti-Human C5 Therapy or cGMP Analogues Arterioscler. Thromb. Vasc. Biol., November 1, 1999; 19(11): 2623 - 2629. [Abstract] [Full Text] [PDF]

				A. Hempel, C. Lindschau, C. Maasch, M. Mahn, R. Bychkov, T. Noll, F. C. Luft, and H. Haller Calcium Antagonists Ameliorate Ischemia-Induced Endothelial Cell Permeability by Inhibiting Protein Kinase C Circulation, May 18, 1999; 99(19): 2523 - 2529. [Abstract] [Full Text] [PDF]